CN Bio launches PhysioMimix Bioavailability assay kit Human 18
Explore CN Bio's innovative gut/liver-on-a-chip solution, empowering researchers to accurately profile human oral drug bioavailability in vitro
Explore CN Bio's innovative gut/liver-on-a-chip solution, empowering researchers to accurately profile human oral drug bioavailability in vitro
This new development will allow mRNA therapies to be manufactured in Poland for drug developers to treat COVID, potential forms of cancer, and more
Attend this expert webinar to stay ahead of the latest technological breakthroughs in the monoclonal gammopathy field
Research results highlight how the Idylla™ System allows for the analysis of small biological samples, including cytological specimens, giving healthcare providers critical information within hours so they can make timely treatment decisions
New guidelines for SARS-CoV-2 genomic surveillance aim to standardize NGS practices
New proprietary assembly technology pairs with groundbreaking complex DNA synthesis platform to deliver sequence-perfect clonal DNA as long as 5 kb
Promega and QuantumCyte sign co-marketing agreement aimed at enhancing the workflow solutions available to clinical laboratories
Learn how biomarkers can be used to transform drug approval and patient management in neurodegenerative medicine
inCerebro enhances CDD's capabilities in managing, sharing, and analysing complex research data, from its proprietary inCerebro MIND platform (Modelling with Intelligence for Novel Drugs).
Guest editorial by Arindam Ghosh, MBBS, PhD, a physician-scientist by training with extensive experience in neurodegenerative and neuropsychiatric disorders, particularly Alzheimer’s disease and dementia